Safety Alert for ICDs and CRT-Ds programmed with Merlin Programmer Software Version 17.2.2 rev. 0

According to Department of Health, this safety alert involved a device in Hong Kong that was produced by St.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Date
    2014-01-28
  • Event Date Posted
    2014-01-28
  • Event Country
  • Event Source
    DH
  • Event Source URL
  • Notes / Alerts
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Extra notes in the data
    Medical Device Safety Alert
  • Reason
    Medical device safety alert: st. jude medical icds and crt-ds programmed with merlin programmer software version 17.2.2 rev. 0 the australia therapeutic goods administration (tga) posted a medical device safety alert concerning implantable cardioverter-defibrillators (icds) and cardiac resynchronization therapy defibrillators (crt-ds) programmed with merlin programmer software version 17.2.2 rev. 0, manufactured by st. jude medical. according to the manufacturer’s information, the affected models include current vr, current accel vr rf, current dr, current accel dr rf, promote, promote accel rf, promote quadra, analyst accel vr rf, analyst accel dr rf, fortify st vr, fortify st dr, fortify assura vr, fortify assura dr, ellipse vr, ellipse dr, unify, unify quadra, unify assura crt-d, quadra assura crt-d, and quadra assura mp crt-d. when using the 17.2.2 software and any parameter that is programmed as part of a single vf detection zone configuration, the sinus redetection value will be inappropriately set to zero milliseconds. as a result, any intrinsic activity following the first shock will be considered a “sinus rate” and the device will diagnose “return to sinus”. therefore, if the arrhythmia was not terminated by the initial high voltage therapy, the ongoing arrhythmia would be considered a new episode causing the next high voltage therapy to also be delivered at the first programmed energy level. the manufacturer advises users of the followings: review st jude medical icd/crt-d patient records for patients with affected devices implanted or seen in clinic starting in september 2013 and programmed to a single vf detection zone with the 17.2.2 software. for patients identified during this review, users should schedule an immediate follow-up visit. for patient devices programmed as described above with 17.2.2 software, st. jude medical will arrange installation of a new software version 17.2.3 to correct this issue. if a patient is seen before the 17.2.3 software is installed, then program the device to a two or three zone configuration, even if one of the zones is strictly a monitor zone. this will resolve the issue when using a programmer with 17.2.2 software. according to the local supplier, products with affected software version 17.2.2 were not distributed in hong kong. for details, please refer to tga websitehttp://www.Tga.Gov.Au/sara/arn-detail.Aspx?k=rc-2014-rn-00034-1 if you are in possession of the product, please contact your supplier for necessary actions. posted on 28 january 2014.

Device

  • Model / Serial
  • Product Description
    Medical Device Safety Alert: St. Jude Medical ICDs and CRT-Ds programmed with Merlin Programmer
  • Manufacturer
    St

Manufacturer

St
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    DH